What in.vent Diagnostics does

in.vent Diagnostica GmbH is a German biotechnology company headquartered in Hennigsdorf bei Berlin, founded in 1997 as a spin-off of the research department of B.R.A.H.M.S. AG. The company specializes in the procurement, processing, and distribution of ethically sourced human biospecimens — primarily serum, plasma, whole blood, and tissues — for use across the in vitro diagnostics (IVD) value chain, including assay development, validation, quality control, and clinical studies. Its own blood collection center 'Studienzentrum — Blut Hilft Forschen', operational since 2018, provides direct donor access and underpins a broad disease-state biobank covering allergies, autoimmune, infectious, thyroid, oncology, fertility, diabetes, and sepsis indications, plus CE-marked controls (HbA1c, Calprotectin, PCT).

The company operates a vertically integrated service portfolio in addition to its catalog products: Enhanced Biobanking for tailored cohort design, full IVD Development from feasibility through CE-marked kits, ICS (in.vent Clinical Services) covering IVDR 2017/746 performance studies and post-market surveillance, biomarker screening and antibody validation via partnership with engine the biomarker company (protein arrays with >10,000 antigens), and temperature-tiered storage and logistics from +2 to +8°C down to liquid nitrogen. Manufacturing and process investments include Karl-Fischer titration for residual moisture measurement and a two-dimensional code system for ERP-integrated inventory.

Revenue is generated through a mix of one-time biospecimen sales (perpetual license per unit/panel/pool) and professional services engagements (IVD development, ICS clinical studies, enhanced biobanking), with storage and delivery as a managed service. Distribution combines a direct enterprise sales team with self-serve online procurement through the CBH Biospecimen Marketplace. The company holds ISO 9001 (since 2003) and ISO 13485 (since 2004) certifications and aligns its practices with IVDR 2017/746, ISO 20916, ISO 20387, GDPR, and the Helsinki and Taipei Declarations. It is privately held with no disclosed external funding, founded in 1997, and led by CEO Dr. Jörg-M. Hollidt.

Name

in.vent Diagnostics

Legal name

in.vent Diagnostica GmbH

Website

https://inventdiagnostica.de

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

11–50 employees

Short description

in.vent Diagnostics is a German biotechnology company (founded 1997, Hennigsdorf) that procures, processes, and distributes ethically sourced human biospecimens — serum, plasma, whole blood, tissues — and provides IVD development and IVDR-compliant clinical study services to IVD manufacturers and research institutions worldwide.

Ownership category

akta.pro rank

Product category

In-vitro Diagnostics Biospecimen Supply and Services

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Blood and Organ Banks (621991), Medical Laboratories (621511)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Services-Medical Laboratories (8071)

akta.pro primary industry

Sample Logistics, Biorepository & IVD Kit Management (Trial Support) (HLAGAEAI)

akta.pro secondary industries

Blood Bank, Transfusion Medicine & Immunohematology (HLAHAAAH), Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables) (HLAHAAAL), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Transfusion Medicine & Immunohematology (Blood Bank) (HLAFAMAG)

Keywords

• Human biospecimen supply
• In-vitro diagnostics services
• Clinical performance studies
• IVD product development
• Biobanking services

Headquarters

HQ city

Hennigsdorf

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Infrastructure, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Human Biospecimen Sales: Sale of ethically sourced human biological materials including serum, plasma, whole blood, tissues, controls, pools, and standards for use throughout the entire value chain of in-vitro diagnostics - from research and development to diagnostic tests and quality assurance.
2. IVD Development Services: Complete IVD development services including cross-platform test systems and controls with CE marking (ELISA kits, rapid tests, automated systems). Full product cycle from feasibility study to CE-marked product.
3. Clinical Services (ICS): Complete all-round package covering every step of diagnostic assay validation including all performance studies, study protocols, and reports. Services include Performance Evaluation Plan, Analytical Performance Studies, Clinical Performance Studies, Data Management, Biostatistics, Performance Evaluation Report, CE-Marking, and Post-Market Surveillance.
4. Biomarker Development and Antibody Validation: Full-service biomarker discovery and validation from sample to upscaling, including procurement of human biospecimens, protein array screening, analysis, and upscaling of sample numbers.
5. Storage and Logistics Services: Full-service storage and logistics for human biomaterials and IVD kits at various temperature ranges from room temperature to liquid nitrogen.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Core offering

in.vent Diagnostics develops, procures, and supplies ethically sourced human biospecimens (serum, plasma, whole blood, tissues) for the in-vitro diagnostics value chain, complemented by IVD development services (from feasibility to CE-marked products), clinical performance studies for IVDR 2017/746 compliance, biomarker discovery and antibody validation, and full-service biobanking/storage/logistics. Primary customers are IVD manufacturers, diagnostic companies, and research facilities worldwide.

Product overview

in.vent Diagnostica is a German company founded in 1997 as a spin-off of B.R.A.H.M.S. AG, specializing in human bio-materials and in-vitro diagnostics (IVD) products and services. The company operates a portfolio of core blood products (serum, plasma, whole blood in normal and disease-state donations), tissue products, and CE-marked controls, complemented by a comprehensive service offering including Enhanced Biobanking, IVD Development, Clinical Services (ICS), a Donation Center (Blut Hilft Forschen), Storage & Delivery, and Biomarker Development via partnership with engine the biomarker company. Products are distributed through the CBH Biospecimen Marketplace online shop. The company holds ISO 9001 and ISO 13485 certifications and serves primarily the diagnostic industry and research facilities.

Differentiator

Problem solved

Functional benefit

Products and services

• Human Blood Products Frozen, fresh or lyophilized blood products including serum, plasma, and whole blood available as panels, bulks, or pools for in-vitro diagnostics research, development, diagnostic tests and quality assurance.
• Normal Donations Panels, pools and individual donations from normal donors for use throughout the value chain of in-vitro diagnostics including research, development, diagnostic tests and quality assurance.
• Allergy Products Human serum and plasma samples from allergic donors including individual donations (panels and bulks) for test system validation and pools/controls for external and internal quality control, covering 197 sIgE allergens & components.
• Diabetes Products Ethically sourced, well-documented diabetes samples with high concentration for validation, control material development and research applications, including HbA1c control samples.
• Thyroid Disease Products Parameter and diagnosis-related biomarkers including TRAb-positive plasma and sera for thyroid diagnostics including Hashimoto and Graves' disease.
• Autoimmune Disease Products Products for autoimmune disease testing including aCCP high positive single units, rheumatoid arthritis products, and proficiency testing materials.
• Infectious Disease Products (TORCH) Products for infectious disease diagnostics including TORCH products, viral and bacterial disease single donations and bulks.
• Pregnancy & Fertility Products Hormone collections and pregnancy-related biospecimens for diagnostic development.
• Oncology Products Patient samples for translational projects and oncology-focused diagnostics development.
• SARS-CoV-2/COVID-19 Products SARS-CoV-2 positive specimens, panels, convalescent plasma, antibody positive samples, and validation products for COVID-19 diagnostics.
• CE-marked Controls CE-certified control products including HbA1c controls, Calprotectin Controls, and PCT Controls for laboratory quality control.
• Tissues & Specialities Human tissue for protein extraction including freshly frozen tissue essential for biomarker research and in-vitro diagnostics development.
• Controls, Pools & Standards Quality controls for internal and external quality control, pools for production of quality controls, calibrators, and standardized products with short delivery times.
• Enhanced Biobanking Service Tailor-made solutions for individual customer and project requirements with variations in sample quality, diagnosis-specific biobanks, clinical definitions, and material types (serum, plasma, human tissue, faeces), multi-ethnic, age and gender-specific sorted.
• IVD Development Service Full range of IVD development including cross-platform test systems, CE-marked ELISA kits, rapid tests, automated systems, and kit-external controls — covering the full product cycle from feasibility study to CE-marked product.
• ICS - in.vent Clinical Services Complete all-round package covering every step of diagnostic assay validation including Performance Evaluation Plan, Analytical Performance Studies, Clinical Performance Studies, Data Management, Biostatistics, Performance Evaluation Report, CE-Marking, and Post-Market Surveillance per IVDR 2017/746.
• Donation Center (Blut Hilft Forschen) Blood collection center for procurement of large amounts of donation material including whole blood, urine, saliva, and stool samples for diagnostic test systems.
• Storage & Delivery Service Full-service storage and logistics for human biomaterials and IVD kits at temperature ranges from +2 to +8°C, -25 to -18°C, -82 to -78°C, and liquid nitrogen.
• Biomarker Development and Antibody Validation Service Protein array-based full service for biomarker discovery and antibody validation in cooperation with engine the biomarker company, screening samples against more than 10,000 human proteins and peptides in a single experiment.

Quantifiable outcome

• 4-week screening cycle for allergy products
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered minor and core.

• NAKO GesundheitsstudieminorStrategic or Co-development Partner · 1 January 2014NAKO is the nationwide health study with 200,000 participants which started in 2014. The aim is to gain better understanding of the development of diseases such as cancer, diabetes, heart attacks to improve prevention, early detection and treatment in Germany. in.vent supports this research project.
• CBH Biospecimen MarketplacecoreChannel Partner/ Reseller/ DistributorClose partnership with CBH Biospecimen Marketplace as distribution partner. CBH ensures digital access and efficient sample procurement while in.vent is responsible for professional storage and quality-assured shipping of biological materials. This collaboration guarantees maximum transparency, safety, and scientific reliability throughout the entire value chain.
• Future DiagnosticscoreStrategic or Co-development PartnerFuture Diagnostics is among Europe's most excellent providers of development and validation services in the sector of diagnostics. Official partner for analytical performance studies and assay development. Both companies follow the same ideals and have benefited from this cooperation since establishment.
• DiagnostikNet BBcoreStrategic or Co-development PartnerFounded in 2007, DiagnostikNet BB forms a synergy from various technology fields to implement marketable innovations. Network brings together diagnostic and equipment manufacturers, suppliers, and users from clinics, routine laboratories and research facilities to cover the entire value chain of in vitro diagnostics. As part of this network, in.vent promotes innovative projects with its services and products.
• engine the biomarker companycoreTechnology or Integrationengine has been carrying out specific biomarker screenings with protein arrays since 2016. Through the biobank, the partnership strengthens the use of technology with sample collectives. Combined with their technology, over 100,000 potential antigens are analyzable in one step.

Scale indicators5 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• Tissue Solutions: Human tissue biospecimen provider serving pharma, biotech, and IVD developers with ethically sourced samples. Comparable to in.vent's tissue & specialities offerings and enhanced biobanking for diagnostic development.
• iSpecimen: Marketplace platform connecting biospecimen suppliers with research and diagnostic buyers. Comparable channel role to in.vent's CBH Biospecimen Marketplace partnership and relevant as a competitive distribution alternative.
• ProteoGenex: Provider of human biospecimens (tissues, biofluids) and molecular services for translational and IVD research. Overlaps with in.vent on disease-state samples and tissue-based biomarker work.
• Discovery Life Sciences: Biospecimen and biobanking provider with disease-state samples, custom collections, and downstream analytical services for diagnostics developers. Overlaps in.vent on disease-state biospecimens and IVDR-aligned sample provenance.
• BioIVT: Global human biospecimen supplier offering serum, plasma, whole blood, tissues, and disease-state collections for IVD and research customers. Directly competes with in.vent across biospecimen catalogs, custom biobanking, and IVD validation services.
• AMSBIO: Distributor and supplier of biospecimens, primary cells, and reagents to research and diagnostic customers in Europe and globally. Comparable in product breadth (serum, plasma, disease-state samples) and European GTM.
• Cambridge Bioscience: UK-based distributor of human biospecimens, primary cells, and life science reagents to research and IVD customers. Comparable distribution model and overlapping product catalog with in.vent, especially in Europe.
• SeraCare (LGC Clinical Diagnostics): Supplies reference materials, controls, calibrators, and biospecimen-based standards for IVD assay development and QC. Directly comparable to in.vent's controls, pools & standards and disease-state biospecimen lines.
• Sanguine Biosciences: Biospecimen provider collecting and processing human samples for research and diagnostics, with custom cohort recruitment. Comparable to in.vent's donation center and disease-state sample collection capabilities.

Broad incumbents

• Charles River Laboratories: Large CRO offering biospecimen procurement, bioanalytical, and IVD/biopharma services across a broad portfolio. Overlaps with in.vent at the high-touch end (custom biobanking, clinical sample studies) but as part of a much wider service suite.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/invent-diagnostica

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about in.vent Diagnostics